TC

Thrinath Chirala

Active Director Managing Director DIN 10483531
DIN 10483531 First appointment Jan 2024 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Thrinath Chirala

Data last updated:

Thrinath Chirala is a Managing Director at Stankhardt Pharmaceuticals Private Limited (since 2024). The company operates in Food And Beverages.

DIN 10483531
Primary Designation Managing Director
Industry Food And Beverages
First Appointment 30 Jan 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director30 Jan 20242022Active

Board colleagues of Thrinath Chirala

NameDINCompanyDesignation
Prudhvi Chirala09531665Stankhardt Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Stankhardt Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Thrinath Chirala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thrinath Chirala

Thrinath Chirala currently holds 1 directorship: Stankhardt Pharmaceuticals Private Limited (Managing Director, since 30 Jan 2024).

Thrinath Chirala was first appointed on 30 Jan 2024 as Managing Director at Stankhardt Pharmaceuticals Private Limited.

The current boards of Thrinath Chirala's companies include Prudhvi Chirala (Stankhardt Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available